Skip to content
Delayed ~15 min

ZBH Zimmer Biomet

Health Care · S&P 500

Next earnings: not announced yet

What 28 analyst firms say about Zimmer Biomet: their latest ratings, price targets and how far the stock is from them. How it works

105.59 USD−1.26 (−1.18%) today
Price as of 6 Nov 16:01 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

−0.5%to the avg target 105.05 USD−0.54 USD
Buy 9 · Hold 17 · Sell 1

27 rated views · 29 analyst/firm records · 28 firms

Latest report22 Oct 2026avg report date 24 Jul
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • S&P 500 · Top Picks · 6MBelow the Radar threshold of 8013
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8043

Recent analyst activity · last 90 days

Our tracked history has 14 reports on ZBH from 13 analyst firms in the last 90 days (28 firms in the past year).

Comparing each firm's latest target with its previous one: 9 raised their price target and 1 left it unchanged.

Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.

Latest observed target change: Bernstein raised its target from $93.00 (set 6 Aug 2026) to $107.00 on 5 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusDavid ToungBuy22 Oct 2026125.00 USD
BairdJeffrey D JohnsonConflictConflicting reports · excluded6 Aug 2026104.00 USD
BarclaysChristopher PasqualeHold7 Oct 2026100.00 USD
BernsteinLee HambrightHold6 Aug 202693.00 USD
BMO Capital MarketsVik ChopraHold28 Sep 202696.00 USD · 8 Jul 2026
BTIGRyan ZimmermanHold14 Jul 2026—
Canaccord GenuityCaitlin RobertsHold10 Aug 2026100.00 USD
CitigroupJoanne WuenschHold5 Oct 202699.00 USD
Citizens JMPDavid TurkalyBuy29 Apr 2026105.00 USD
Evercore ISIVijay KumarBuy7 Oct 2026115.00 USD
Goldman SachsDavid H RomanSell29 Apr 202687.00 USD
JefferiesMatthew C TaylorHold6 Aug 2026105.00 USD
JPMorganRobbie MarcusHold29 Apr 202695.00 USD
Leerink PartnersMichael KratkyHold6 Aug 202697.00 USD
NeedhamMichael MatsonHold5 Aug 2026—
Piper SandlerMatthew O'BrienHold5 Aug 2026—
Raymond JamesJayson T BedfordHold28 Apr 2026—
RBC Capital MarketsKendall AuBuy23 Jul 2026110.00 USD
RBC Capital MarketsShagun SinghBuy6 Aug 2026110.00 USD
RedburnEd Ridley-DayBuy6 Aug 2026117.00 USD
StifelRick WiseBuy6 Aug 2026110.00 USD
TD CowenMathew BlackmanBuy27 Jan 2026109.00 USD
TruistRichard NewitterHold7 Aug 2026106.00 USD
UBSPatrick WoodBuy6 Aug 2026120.00 USD
Weiss RatingsUnnamed analyst—14 Sep 2026—
Wells FargoLawrence H BiegelsenHold6 Aug 2026103.00 USD
William BlairSteven LichtmanHold6 Aug 2026—
Wolfe ResearchMike PolarkHold1 Jul 2026—
Data feed RESEARCHResearch TeamHold25 Aug 2026Conflicting reports · excluded

Partial coverage · checked 6 Nov (6 Nov 2026, 04:05 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.